指南与共识肝胆胰外科围术期管理与 ERAS

腹腔镜胰腺肿瘤手术:EAES临床共识会议解读

Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference.
指南 / 共识 · Surg Endosc · 2017-02-15

欧洲内镜外科协会(EAES)组织国际专家组,通过Delphi流程和会议讨论,针对腹腔镜胰腺手术(LAPS)在胰腺肿瘤患者中的应用制定共识声明与临床推荐。共识认为LAPS总体安全,尤其在经验丰富者手中,在术中出血、术后恢复和生活质量方面优于开腹,但证据主要基于回顾性病例对照研究,尚无RCT发表。

要点

  • LAPS包括腹腔镜远端胰腺切除、胰十二指肠切除、剜除术、中央胰腺切除及超声。
  • LDP可行且安全,已在许多中心开展;LPD仅限于少数中心。
  • 证据以回顾性研究为主,存在选择偏倚,亟需RCT和登记研究。

核心结论

  • LAPS处于国际IDEAL框架定义的发展与探索阶段。
  • LDP可行且安全,已在许多中心开展;LPD仅限于少数中心。
  • 需RCT和登记研究进一步评估LAPS。

研究设计与样本

  • EAES组织国际专家组,基于文献批判性评估形成证据声明,经Delphi流程和面对面会议讨论,并在EAES大会全体会议及网络调查中展示。

主要发现

  • LAPS总体安全,尤其在经验丰富者手中。
  • LAPS在术中出血、术后恢复和生活质量方面优于开腹。

关键数值与推荐

  • 证据主要基于回顾性病例对照研究及其系统综述,受选择偏倚影响。
  • 尚无RCT发表,但欧洲有四项RCT正在进行。

临床怎么用

  • LDP可在有经验的中心开展,LPD应限于少数中心。
  • 开展LAPS需关注经验积累并参与RCT或登记研究。

局限性

  • 证据以回顾性研究为主,存在选择偏倚。
  • 尚无RCT发表。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Introduced more than 20 years ago, laparoscopic pancreatic surgery (LAPS) has not reached a uniform acceptance among HPB surgeons. As a result, there is no consensus regarding its use in patients with pancreatic neoplasms. This study, organized by the European Association for Endoscopic Surgery (EAES), aimed to develop consensus statements and clinical recommendations on the application of LAPS in these patients. METHODS: An international panel of experts was selected based on their clinical and scientific expertise in laparoscopic and open pancreatic surgery. Each panelist performed a critical appraisal of the literature and prepared evidence-based statements assessed by other panelists during Delphi process. The statements were further discussed during a one-day face-to-face meeting followed by the second round of Delphi. Modified statements were presented at the plenary session of the 24th International Congress of the EAES in Amsterdam and in a web-based survey. RESULTS: LAPS included laparoscopic distal pancreatectomy (LDP), pancreatoduodenectomy (LPD), enucleation, central pancreatectomy, and ultrasound. In general, LAPS was found to be safe, especially in experienced hands, and also advantageous over an open approach in terms of intraoperative blood loss, postoperative recovery, and quality of life. Eighty-five percent or higher proportion of responders agreed with the majority (69.5%) of statements. However, the evidence is predominantly based on retrospective case-control studies and systematic reviews of these studies, clearly affected by selection bias. Furthermore, no randomized controlled trials (RCTs) have been published to date, although four RCTs are currently underway in Europe. CONCLUSIONS: LAPS is currently in its development and exploration stages, as defined by the international IDEAL framework for surgical innovation. LDP is feasible and safe, performed in many centers, while LPD is limited to few centers. RCTs and registry studies are essential to proceed with the assessment of LAPS.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Edwin B, Sahakyan MA, Abu Hilal M, et al. Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference. Surg Endosc. 2017. PMID: 28205034. doi:10.1007/s00464-017-5414-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。